Explicyte Immuno-Oncology - Cancer Immunotherapy CRO Services
Cancer Immunotherapy CRO Services
Discovery
Custom biospecimen sourcing
Target identification
Target expression profiling
Preclinical
Tumor killing
Tumor sensitization
Activation & immune checkpoint inhibition
Antibody-dependent cell cytotoxicity (ADCC)
Tumor antigen-specific killing
Bispecific T cell engager (BiTE) killing
Antibody-Drug Conjugate (ADC) killing
Immuno-modulation
Immune cell activation
Immune cell migration
Mixed lymphocyte reaction (MLR)
Macrophage assays
TLS-GC reaction
Cytokine release syndrome
Featured
Xenium for cells
Trials
Biomarker analysis
TLS detection & evaluation
Platforms
Spatial Biology
Xenium: Single-cell spatial transcriptomics
GeoMx: Digital spatial profiling
Visium HD: Whole-Transcriptome Spatial Biology
IHC/IF: Digital pathology
Multi-Omics
Single-cell RNA Seq
Proteomics
Flow cytometry
Bioinformatics
10x Genomics Datasets
Bulk RNA-seq & GeoMx DSP Datasets
mIF & IHC Image Analysis
About
About Explicyte
Science
Commitments
News
Careers
Contact us
Toggle menu
Contact us
CRO Services
Explicyte Immuno-Oncology
>
CRO Services
View Details
RNA Sequencing
View Details
Target identification & validation for cancer immunotherapies
View Details
Sarcoma
View Details
Renal Cancer
View Details
Glioma
View Details
Colon cancer
View Details
Colon Cancer
View Details
Triple Negative Breast Cancer
View Details
Breast Cancer
View Details
Immune cell tumor killing
View Details
Antibody-dependent cell cytotoxicity (ADCC)
View Details
Macrophage assays
Previous page
1
2
3
4
5
Next page
WordPress Lightbox
